Zhao Wenrong, Geng Peng, Li Yunyun, Wei Xiaohe, Cheng Jingxin
Department of Obstetrics and Gynecology, East Hospital, School of Medicine, Tongji University Shanghai, China.
Research Center for Translation Medicine, East Hospital, School of Medicine, Tongji University Shanghai, China.
Int J Clin Exp Pathol. 2017 Dec 1;10(12):11489-11495. eCollection 2017.
Endometrial carcinoma is one of the most common gynecological malignant tumors. Recent evidence has demonstrated that miR-21 is involved in the proliferation and invasion of endometrial carcinoma. This study aims to explore the effect of biological behavior of miR-21 on endometrial carcinoma its relationship with PTEN. First, Collected endometrial carcinoma and adjacent non-tumor issues, the relative expression levels of miR-21 and PTEN mRNA were quantitated by real-time polymerase chain reaction (RT-PCR). Next, endometrial carcinoma cell line Ishikawa were transfected with miR-21 inhibitor. After transfection, real-time PCR was used to detect the expression levels of miR-21. Then, the cells proliferation, the apoptotic rates and the invasion rates were detected by MTT method, flow cytometry, and Transwell assay. The expression levels of p-PTEN and PTEN proteins were detected by western blot. The results showed that miR-21 was significantly up-regulation and PTEN was down-regulation in endometrial carcinoma tissues (P < 0.05). miR-21 inhibitor were successfully transfected into Ishikawa cell. The cell proliferation activity, and the number invasion cells in the miR-21 inhibitor group was obviously lower than the miR-21 NC group and Normal group (P < 0.05). The apoptosis rate in the miR-21 inhibitor group was significantly higher than the miR-21 NC group and Normal group (P < 0.05). The expression levels of p-PTEN in miR-21 inhibitor groups were significantly higher than miR-21 NC group and Normal group (P < 0.05). Therefore, we concluded that miR-21 could promote cell proliferation and invasion ability, and inhibite cell apoptosis in endometrial carcinoma partially by regulating its target gene PTEN on post-transcriptional level. In brief, miR-21 may be a new early diagnosis mark and therapy target in endometrial carcinoma.
子宫内膜癌是最常见的妇科恶性肿瘤之一。最近的证据表明,miR-21参与子宫内膜癌的增殖和侵袭。本研究旨在探讨miR-21对子宫内膜癌生物学行为的影响及其与PTEN的关系。首先,收集子宫内膜癌及相邻非肿瘤组织,采用实时聚合酶链反应(RT-PCR)定量检测miR-21和PTEN mRNA的相对表达水平。接下来,用miR-21抑制剂转染子宫内膜癌细胞系Ishikawa。转染后,用实时PCR检测miR-21的表达水平。然后,采用MTT法、流式细胞术和Transwell实验检测细胞增殖、凋亡率和侵袭率。用蛋白质免疫印迹法检测p-PTEN和PTEN蛋白的表达水平。结果显示,miR-21在子宫内膜癌组织中显著上调,PTEN下调(P<0.05)。miR-21抑制剂成功转染至Ishikawa细胞。miR-21抑制剂组的细胞增殖活性和侵袭细胞数明显低于miR-21阴性对照组和正常组(P<0.05)。miR-21抑制剂组的凋亡率明显高于miR-21阴性对照组和正常组(P<0.05)。miR-21抑制剂组p-PTEN的表达水平明显高于miR-21阴性对照组和正常组(P<0.05)。因此,我们得出结论,miR-21可促进子宫内膜癌细胞增殖和侵袭能力,并通过转录后水平调控其靶基因PTEN部分抑制细胞凋亡。简而言之,miR-21可能是子宫内膜癌新的早期诊断标志物和治疗靶点。